These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16927148)

  • 1. Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients.
    Holtmann MH; Krummenauer F; Claas C; Kremeyer K; Lorenz D; Rainer O; Vogel I; Böcker U; Böhm S; Büning C; Duchmann R; Gerken G; Herfarth H; Lügering N; Kruis W; Reinshagen M; Schmidt J; Stallmach A; Stein J; Sturm A; Galle PR; Hommes DW; D'Haens G; Rutgeerts P; Neurath MF
    Dig Dis Sci; 2006 Sep; 51(9):1516-24. PubMed ID: 16927148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Azathioprine in inflammatory bowel disease].
    Leite S; Ribeiro JM; Lima SC; Barroso S; Cotter J
    Acta Med Port; 2009; 22(1):33-40. PubMed ID: 19341591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients.
    Holtmann MH; Krummenauer F; Claas C; Kremeyer K; Lorenz D; Rainer O; Vogel I; Böcker U; Böhm S; Büning C; Duchmann R; Gerken G; Herfarth H; Lügering N; Kruis W; Reinshagen M; Schmidt J; Stallmach A; Stein J; Sturm A; Galle PR; Hommes DW; D'Haens G; Rutgeerts P; Neurath MF
    Dig Dis Sci; 2010 Apr; 55(4):1066-78. PubMed ID: 19513841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.
    Fraser AG; Orchard TR; Jewell DP
    Gut; 2002 Apr; 50(4):485-9. PubMed ID: 11889067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice.
    Saibeni S; Virgilio T; D'Incà R; Spina L; Bortoli A; Paccagnella M; Peli M; Sablich R; Meucci G; Colombo E; Benedetti G; Girelli CM; Casella G; Grasso G; de Franchis R; Vecchi M
    Dig Liver Dis; 2008 Oct; 40(10):814-20. PubMed ID: 18479986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Crohn disease in the Czech Republic in the years 1990 to 2001 and assessment of pediatric population with inflammatory bowel disease.
    Pozler O; Maly J; Bonova O; Dedek P; Frühauf P; Havlickova A; Janatova T; Jimramovsky F; Klimova L; Klusacek D; Kocourkova D; Kolek A; Kotalova R; Marx D; Nevoral J; Petro R; Petru O; Plasilova I; Seidl Z; Sekyrova I; Semendak N; Schreierova I; Stanek J; Sykora J; Sulakova A; Toukalkova L; Travnickova R; Volf V; Zahradnicek L; Zenisková I
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):186-9. PubMed ID: 16456413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of methotrexate in an inflammatory bowel diseases based on the review of the current literature].
    Klimczak K; Łykowska-Szuber L; Krela-Kaźmierczak I; Eder P; Szymczak A; Stawczyk-Eder K; Linke K
    Wiad Lek; 2016; 69(2 Pt 2):262-6. PubMed ID: 27487545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Bowel Disease Patients Are at Increased Risk of Invasive Pneumococcal Disease: A Nationwide Danish Cohort Study 1977-2013.
    Kantsø B; Simonsen J; Hoffmann S; Valentiner-Branth P; Petersen AM; Jess T
    Am J Gastroenterol; 2015 Nov; 110(11):1582-7. PubMed ID: 26346865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is there any interest to dose the azathioprine's metabolites during inflammatory bowel diseases?].
    Melaouhia S; Fékih M; Ferchichi H; Bouissorra H; Ben Mustapha N; Boubaker J; Filali A; Lakhal M; Klouz A
    Therapie; 2013; 68(5):313-20. PubMed ID: 24225042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study.
    Herrlinger KR; Diculescu M; Fellermann K; Hartmann H; Howaldt S; Nikolov R; Petrov A; Reindl W; Otte JM; Stoynov S; Strauch U; Sturm A; Voiosu R; Ammendola A; Dietrich B; Hentsch B; Stange EF
    J Crohns Colitis; 2013 Sep; 7(8):636-43. PubMed ID: 23078909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of inflammatory bowel disease in young Greek Army male recruits from 2006 to 2018: a 13-year retrospective study from a tertiary center.
    Kyriakos N; Papaefthymiou A; Giakoumis M; Galanopoulos M; Galanis P; Mylonas I; Karatzas P; Mantzaris G; Liatsos C
    Eur J Gastroenterol Hepatol; 2022 Feb; 34(2):153-160. PubMed ID: 33653987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammatory bowel disease--diagnosis and therapy].
    Vogt W
    Praxis (Bern 1994); 2005 Feb; 94(5):145-50. PubMed ID: 15745379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of azathioprine in IBD: modern aspects of an old drug.
    Louis E; Irving P; Beaugerie L
    Gut; 2014 Nov; 63(11):1695-9. PubMed ID: 24943205
    [No Abstract]   [Full Text] [Related]  

  • 19. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
    Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003.
    Vijverman A; Piront P; Belaiche J; Louis E
    Acta Gastroenterol Belg; 2006; 69(1):1-4. PubMed ID: 16673554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.